These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


316 related items for PubMed ID: 8141787

  • 1. The region around residue 115 of human bactericidal/permeability-increasing protein is not involved in lipopolysaccharide binding or bactericidal activity. Chemical synthesis and expression of a gene coding for the active domain and characterization of recombinant proteins.
    Qi SY, Li Y, O'Connor CD.
    Biochem J; 1994 Mar 15; 298 Pt 3(Pt 3):711-8. PubMed ID: 8141787
    [Abstract] [Full Text] [Related]

  • 2. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope.
    Weiss J, Muello K, Victor M, Elsbach P.
    J Immunol; 1984 Jun 15; 132(6):3109-15. PubMed ID: 6373924
    [Abstract] [Full Text] [Related]

  • 3. Salmonella typhimurium responses to a bactericidal protein from human neutrophils.
    Qi SY, Li Y, Szyroki A, Giles IG, Moir A, O'Connor CD.
    Mol Microbiol; 1995 Aug 15; 17(3):523-31. PubMed ID: 8559071
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils.
    Ooi CE, Weiss J, Doerfler ME, Elsbach P.
    J Exp Med; 1991 Sep 01; 174(3):649-55. PubMed ID: 1875165
    [Abstract] [Full Text] [Related]

  • 7. Human lipopolysaccharide-binding protein potentiates bactericidal activity of human bactericidal/permeability-increasing protein.
    Horwitz AH, Williams RE, Nowakowski G.
    Infect Immun; 1995 Feb 01; 63(2):522-7. PubMed ID: 7822017
    [Abstract] [Full Text] [Related]

  • 8. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
    Elsbach P, Weiss J.
    Immunobiology; 1993 Apr 01; 187(3-5):417-29. PubMed ID: 8330906
    [Abstract] [Full Text] [Related]

  • 9. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli.
    Capodici C, Chen S, Sidorczyk Z, Elsbach P, Weiss J.
    Infect Immun; 1994 Jan 01; 62(1):259-65. PubMed ID: 8262637
    [Abstract] [Full Text] [Related]

  • 10. Role of charge and hydrophobic interactions in the action of the bactericidal/permeability-increasing protein of neutrophils on gram-negative bacteria.
    Weiss J, Victor M, Elsbach P.
    J Clin Invest; 1983 Mar 01; 71(3):540-9. PubMed ID: 6338040
    [Abstract] [Full Text] [Related]

  • 11. Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification.
    Mannion BA, Kalatzis ES, Weiss J, Elsbach P.
    J Immunol; 1989 Apr 15; 142(8):2807-12. PubMed ID: 2539411
    [Abstract] [Full Text] [Related]

  • 12. Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli.
    Mannion BA, Weiss J, Elsbach P.
    J Clin Invest; 1990 Mar 15; 85(3):853-60. PubMed ID: 2179269
    [Abstract] [Full Text] [Related]

  • 13. Identification and expression analysis on bactericidal permeability-increasing protein (BPI)/lipopolysaccharide-binding protein (LBP) of ark shell, Scapharca broughtonii.
    Mao Y, Zhou C, Zhu L, Huang Y, Yan T, Fang J, Zhu W.
    Fish Shellfish Immunol; 2013 Sep 15; 35(3):642-52. PubMed ID: 23742867
    [Abstract] [Full Text] [Related]

  • 14. Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution.
    Beamer LJ, Carroll SF, Eisenberg D.
    Science; 1997 Jun 20; 276(5320):1861-4. PubMed ID: 9188532
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Structural determinants of the action against Escherichia coli of a human inflammatory fluid phospholipase A2 in concert with polymorphonuclear leukocytes.
    Weiss J, Inada M, Elsbach P, Crowl RM.
    J Biol Chem; 1994 Oct 21; 269(42):26331-7. PubMed ID: 7929350
    [Abstract] [Full Text] [Related]

  • 17. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein.
    Levy O, Martin S, Eichenwald E, Ganz T, Valore E, Carroll SF, Lee K, Goldmann D, Thorne GM.
    Pediatrics; 1999 Dec 21; 104(6):1327-33. PubMed ID: 10585984
    [Abstract] [Full Text] [Related]

  • 18. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J, Elsbach P, Shu C, Castillo J, Grinna L, Horwitz A, Theofan G.
    J Clin Invest; 1992 Sep 21; 90(3):1122-30. PubMed ID: 1522221
    [Abstract] [Full Text] [Related]

  • 19. Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis.
    Calvano SE, Thompson WA, Marra MN, Coyle SM, de Riesthal HF, Trousdale RK, Barie PS, Scott RW, Moldawer LL, Lowry SF.
    Arch Surg; 1994 Feb 21; 129(2):220-6. PubMed ID: 7508221
    [Abstract] [Full Text] [Related]

  • 20. Bactericidal/permeability-increasing protein, a lipopolysaccharide-specific protein on the surface of human peripheral blood monocytes.
    Dentener MA, Francot GJ, Buurman WA.
    J Infect Dis; 1996 Jan 21; 173(1):252-5. PubMed ID: 8537670
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.